These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 24874727)
1. Degradation of mutant p53H175 protein by Zn(II) through autophagy. Garufi A; Pucci D; D'Orazi V; Cirone M; Bossi G; Avantaggiati ML; D'Orazi G Cell Death Dis; 2014 May; 5(5):e1271. PubMed ID: 24874727 [TBL] [Abstract][Full Text] [Related]
2. A fluorescent curcumin-based Zn(II)-complex reactivates mutant (R175H and R273H) p53 in cancer cells. Garufi A; Trisciuoglio D; Porru M; Leonetti C; Stoppacciaro A; D'Orazi V; Avantaggiati M; Crispini A; Pucci D; D'Orazi G J Exp Clin Cancer Res; 2013 Oct; 32(1):72. PubMed ID: 24220325 [TBL] [Abstract][Full Text] [Related]
3. Zn(II)-curc targets p53 in thyroid cancer cells. Garufi A; D'Orazi V; Crispini A; D'Orazi G Int J Oncol; 2015 Oct; 47(4):1241-8. PubMed ID: 26314369 [TBL] [Abstract][Full Text] [Related]
4. Interplay between Endoplasmic Reticulum (ER) Stress and Autophagy Induces Mutant p53H273 Degradation. Garufi A; Federici G; Gilardini Montani MS; Crispini A; Cirone M; D'Orazi G Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32138264 [TBL] [Abstract][Full Text] [Related]
5. Proteasomal and autophagy-mediated degradation of mutp53 proteins through mitochondria-targeting aggregation-induced-emission materials. Wang M; Yang Z; Song Y; Wei P; Ishiwme N; Wang L; Zhang H; Jing M; Gao M; Wen L; Zhang Y Acta Biomater; 2022 Sep; 150():402-412. PubMed ID: 35931280 [TBL] [Abstract][Full Text] [Related]
7. Identification of a druggable protein-protein interaction site between mutant p53 and its stabilizing chaperone DNAJA1. Tong X; Xu D; Mishra RK; Jones RD; Sun L; Schiltz GE; Liao J; Yang GY J Biol Chem; 2021; 296():100098. PubMed ID: 33208462 [TBL] [Abstract][Full Text] [Related]
8. A ruthenium(II)-curcumin compound modulates NRF2 expression balancing the cancer cell death/survival outcome according to p53 status. Garufi A; Baldari S; Pettinari R; Gilardini Montani MS; D'Orazi V; Pistritto G; Crispini A; Giorno E; Toietta G; Marchetti F; Cirone M; D'Orazi G J Exp Clin Cancer Res; 2020 Jun; 39(1):122. PubMed ID: 32605658 [TBL] [Abstract][Full Text] [Related]
9. Overaccumulation of p53-mediated autophagy protects against betulinic acid-induced apoptotic cell death in colorectal cancer cells. Wang S; Wang K; Zhang C; Zhang W; Xu Q; Wang Y; Zhang Y; Li Y; Zhang Y; Zhu H; Song F; Lei Y; Bu Y Cell Death Dis; 2017 Oct; 8(10):e3087. PubMed ID: 28981110 [TBL] [Abstract][Full Text] [Related]
11. Dissecting the pathways that destabilize mutant p53: the proteasome or autophagy? Choudhury S; Kolukula VK; Preet A; Albanese C; Avantaggiati ML Cell Cycle; 2013 Apr; 12(7):1022-9. PubMed ID: 23466706 [TBL] [Abstract][Full Text] [Related]
12. p53-R273H Sustains ROS, Pro-Inflammatory Cytokine Release and mTOR Activation While Reducing Autophagy, Mitophagy and UCP2 Expression, Effects Prevented by wtp53. Romeo MA; Gilardini Montani MS; Benedetti R; Arena A; D'Orazi G; Cirone M Biomolecules; 2021 Feb; 11(3):. PubMed ID: 33668399 [No Abstract] [Full Text] [Related]
13. The activating transcription factor 3 protein suppresses the oncogenic function of mutant p53 proteins. Wei S; Wang H; Lu C; Malmut S; Zhang J; Ren S; Yu G; Wang W; Tang DD; Yan C J Biol Chem; 2014 Mar; 289(13):8947-59. PubMed ID: 24554706 [TBL] [Abstract][Full Text] [Related]
14. Autophagy induced by SAHA affects mutant P53 degradation and cancer cell survival. Foggetti G; Ottaggio L; Russo D; Mazzitelli C; Monti P; Degan P; Miele M; Fronza G; Menichini P Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30745455 [TBL] [Abstract][Full Text] [Related]
15. Δ40p53 is involved in the inactivation of autophagy and contributes to inhibition of cell death in HCT116-Δ40p53 cells. Zang Y; Shi Y; Liu K; Qiao L; Guo X; Chen D Oncotarget; 2017 Feb; 8(8):12754-12763. PubMed ID: 28061446 [TBL] [Abstract][Full Text] [Related]
16. Reactivation of mutant p53 by a dietary-related compound phenethyl isothiocyanate inhibits tumor growth. Aggarwal M; Saxena R; Sinclair E; Fu Y; Jacobs A; Dyba M; Wang X; Cruz I; Berry D; Kallakury B; Mueller SC; Agostino SD; Blandino G; Avantaggiati ML; Chung FL Cell Death Differ; 2016 Oct; 23(10):1615-27. PubMed ID: 27258787 [TBL] [Abstract][Full Text] [Related]
17. Glutathionylation-dependent proteasomal degradation of wide-spectrum mutant p53 proteins by engineered zeolitic imidazolate framework-8. Zhang Y; Huang X; Wang L; Cao C; Zhang H; Wei P; Ding H; Song Y; Chen Z; Qian J; Zhong S; Liu Z; Wang M; Zhang W; Jiang W; Zeng J; Yao G; Wen LP Biomaterials; 2021 Apr; 271():120720. PubMed ID: 33639563 [TBL] [Abstract][Full Text] [Related]
18. Mutant p53 drives the loss of heterozygosity by the upregulation of Nek2 in breast cancer cells. Ghaleb A; Padellan M; Marchenko N Breast Cancer Res; 2020 Dec; 22(1):133. PubMed ID: 33267874 [TBL] [Abstract][Full Text] [Related]
19. The PI3K/mTOR dual inhibitor NVP-BEZ235 stimulates mutant p53 degradation to exert anti-tumor effects on triple-negative breast cancer cells. Cai J; Xia J; Zou J; Wang Q; Ma Q; Sun R; Liao H; Xu L; Wang D; Guo X FEBS Open Bio; 2020 Apr; 10(4):535-545. PubMed ID: 32027103 [TBL] [Abstract][Full Text] [Related]
20. Reactivation of mutant p53 by capsaicin, the major constituent of peppers. Garufi A; Pistritto G; Cirone M; D'Orazi G J Exp Clin Cancer Res; 2016 Sep; 35(1):136. PubMed ID: 27599722 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]